JPRN-UMIN000021309已完成1 期
Assessment of the safety of nicotinamide mononucleotide (NMN) in healthy subjects; phase I study. The clinical trial to evaluate metabolic-syndrome-related parameters to develop NMN as Foods with Function Claims. - Assessment of the safety of nicotinamide mononucleotide (NMN).
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 60years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1 the subjects with a previous history of diseases. 2 the subjects with malignant neoplasms. 3 the subjects with serious infections. 4 the subjects with psychiatric disorders. 5 the subjects with ophthalmic disorder. 6 the subjects with allergic disorders. 7 the subjects who are regarded as inadequate by the investigator.
研究者
相似试验
已完成
2 期
Assessment of the safety of long-term nicotinamide mononucleotide (NMN) in healthy subjects; phase II study. The clinical trial to evaluate metabolic-syndrome-related parameters to develop NMN as Foods with Function Claims.JPRN-UMIN000030609Keio University School of Medicine13
招募中
1 期
Pilot study of safety and efficacy of nicotinamide (vitamin B3) in OPA1 Dominant Optic Atrophy -NICOPA1-TODominant Optic AtrophyCTIS2023-506214-52-00Centre Hospitalier Universitaire D Angers25
招募中
2 期
Efficacy of NMN for tinnitustinnitusJPRN-jRCTs041220129Takakura Hiromasa60
招募中
Unknown
Evaluation of the effects of nicotineamide mononucleotide administered intravenously to healthy subjects.healthy subjectsJPRN-UMIN000049123TOKYO GINZA WELLNESS & AGING CLINIC20
进行中（未招募）
不适用
Efficacy and safety following use of a novel nicotine replacement therapy. A multicenter, randomized, double blind, placebo-controlled, parallel group, 52-week study in smokers motivated to quit.For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit abruptly.MedDRA version: 9.1Level: LLTClassification code 10008374Term: Cessation of smokingMedDRA version: 9.1Level: LLTClassification code 10053325Term: Smoking cessation therapyMedDRA version: 9.1Level: LLTClassification code 10059612Term: Tobacco withdrawal symptomsEUCTR2008-006845-13-DEMcNeil AB (Johnson & Johnson Consumer and Personal Products Worldwide, J&J CPPW)465